pre-miRNA Information
pre-miRNA hsa-mir-132   
Genomic Coordinates chr17: 2049908 - 2050008
Description Homo sapiens miR-132 stem-loop
Comment This miRNA sequence is predicted based on homology to a verified miRNA from mouse .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-132-3p
Sequence 59| UAACAGUCUACAGCCAUGGUCG |80
Evidence Experimental
Experiments Cloned
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1211938237 4 dbSNP
rs1173831908 7 dbSNP
rs751170675 10 dbSNP
rs1392699403 15 dbSNP
rs1022001830 17 dbSNP
rs1431105016 21 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BNMH41 miR-132 Pharmacodynamic Biomarker (PDY) Clinical/Experimental Data Concentration Decrease Plasma Quantitative reverse transcription PCR
Gene Information
Gene Symbol TJAP1   
Synonyms PILT, TJP4
Description tight junction associated protein 1
Transcript NM_001146016   
Other Transcripts NM_001146017 , NM_001146018 , NM_001146019 , NM_001146020 , NM_080604   
Expression
Putative miRNA Targets on TJAP1
3'UTR of TJAP1
(miRNA target sites are highlighted)
>TJAP1|NM_001146016|3'UTR
   1 GGCCCCTGCTGGCCTTCCTGCCATTGCTGCACCAGGACTGCAAGGAGTCCCCACACCTTGGCAGCTCAGGGTCCCCAGTC
  81 CAAGCCCTTGACCTCTCCTCTATCCAGACCCGCACAGCTGTTTCCTGTGTGGATGGGGTCAGGTTGTGGGCCATGCCAGG
 161 CCTGTCAGCTGCGTTGACTGACTGCAGCAGCTTGCCTCATGGTTTTCCCTTTTTCTTAGAATATTTATTCTTCAGAGGTA
 241 ACATGCAGTTGGGTCTCAAGACCTTTCCTCCAATCAGCCCAACCCAGCCCAGACTGGGCTTTTCTGGGGAGCTGAGGAGT
 321 TTATCAGTATTCATCTTCCATCCTTTCATAGTCACAAGTTTTGTTATTTTGTTTTTTTTTGGGGGTGATGGTGTAATTGT
 401 TAACCTCATTTCCGTTTCCTACCTGTTTGCTTCCCCCCCCAGTCCTCCGCATGAGCTGTTGCCCTCCAGGGGCCTGGCAC
 481 AGCTGGCCTTGGGGACGAGGGAGAGGACTGATTCAGGGCCCCCTCAGCTGTCTCCTCCCTCCCTCTGGAAAGGAGGGTGG
 561 GGCTCAGGGGCCTCAAGCTGGGCTCTGTGTGAGGCCTGGCCCCCACTCCCAACCTTGGCTCTAGACTGTTACTCTTAAGC
 641 TTTGAGAAATTTTCACATTGATGACTATTTTAAAATCAAATAAAACTATTTTACTGGTATGAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' gcUGGUACCGACAUCUGACAAu 5'
            ||| ||||| ||||||||| 
Target 5' caACCTTGGCTCTAGACTGTTa 3'
610 - 631 184.00 -24.50
2
miRNA  3' gcUGGUACCGACAU----CUGACaau 5'
            :|||| |||| |    |||||   
Target 5' ctGCCATTGCTGCACCAGGACTGcaa 3'
18 - 43 126.00 -14.72
3
miRNA  3' gcUGGUACCGACAUCUGACAAu 5'
            || | ||  | :||||| | 
Target 5' ggACGA-GGGAGAGGACTGATt 3'
493 - 513 119.00 -11.72
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN30566374 26 COSMIC
COSN7883517 98 COSMIC
COSN9907478 224 COSMIC
COSN29234837 276 COSMIC
COSN29610894 381 COSMIC
COSN7790609 381 COSMIC
COSN28201786 384 COSMIC
COSN31543668 415 COSMIC
COSN24381016 441 COSMIC
COSN31484464 498 COSMIC
COSN31579754 552 COSMIC
COSN31584412 647 COSMIC
COSN28718048 678 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1309687936 4 dbSNP
rs1353310853 6 dbSNP
rs755213132 8 dbSNP
rs1292862879 13 dbSNP
rs939207742 19 dbSNP
rs1428775172 25 dbSNP
rs1387938611 27 dbSNP
rs1247013338 30 dbSNP
rs778926832 32 dbSNP
rs1339373225 35 dbSNP
rs1195217769 39 dbSNP
rs1433576355 45 dbSNP
rs34182777 46 dbSNP
rs1202589923 48 dbSNP
rs1056199588 54 dbSNP
rs1189442857 58 dbSNP
rs1481655632 74 dbSNP
rs114849138 79 dbSNP
rs1204543500 82 dbSNP
rs1351730991 86 dbSNP
rs188240163 91 dbSNP
rs1301167127 95 dbSNP
rs1234360646 101 dbSNP
rs1329758668 102 dbSNP
rs1299784907 103 dbSNP
rs1393718541 106 dbSNP
rs1235841194 111 dbSNP
rs1027563724 112 dbSNP
rs538642168 113 dbSNP
rs1368262694 121 dbSNP
rs554150390 124 dbSNP
rs1466333650 128 dbSNP
rs1376923550 129 dbSNP
rs1281442493 132 dbSNP
rs1173852298 137 dbSNP
rs1341747883 142 dbSNP
rs887446342 144 dbSNP
rs1007185929 146 dbSNP
rs1482128274 149 dbSNP
rs115466806 154 dbSNP
rs1201290410 163 dbSNP
rs1344751472 168 dbSNP
rs546208567 173 dbSNP
rs1276869405 174 dbSNP
rs1330375046 175 dbSNP
rs1483415781 175 dbSNP
rs965757240 180 dbSNP
rs975815762 184 dbSNP
rs146145333 199 dbSNP
rs1335776555 208 dbSNP
rs77082223 211 dbSNP
rs1300796970 219 dbSNP
rs1431331970 222 dbSNP
rs568842238 223 dbSNP
rs777647378 226 dbSNP
rs915456392 231 dbSNP
rs1158400364 241 dbSNP
rs1471635653 244 dbSNP
rs537619591 254 dbSNP
rs749273668 256 dbSNP
rs1200766205 264 dbSNP
rs1395398511 266 dbSNP
rs946714077 271 dbSNP
rs1442004558 272 dbSNP
rs1448508459 274 dbSNP
rs1207211329 280 dbSNP
rs1465666502 283 dbSNP
rs543571269 285 dbSNP
rs561940056 286 dbSNP
rs72857288 292 dbSNP
rs1056468852 295 dbSNP
rs1244887356 302 dbSNP
rs1339471300 303 dbSNP
rs572214188 306 dbSNP
rs1436980925 308 dbSNP
rs765404221 314 dbSNP
rs1304642339 322 dbSNP
rs55869200 329 dbSNP
rs1364835475 334 dbSNP
rs865891986 336 dbSNP
rs1455634417 348 dbSNP
rs115171506 350 dbSNP
rs1163848309 350 dbSNP
rs959326033 354 dbSNP
rs1300067956 358 dbSNP
rs527264442 359 dbSNP
rs1049459537 363 dbSNP
rs1247859153 367 dbSNP
rs887673671 368 dbSNP
rs1007657064 372 dbSNP
rs577275176 372 dbSNP
rs1220965297 373 dbSNP
rs1263705027 374 dbSNP
rs180905262 381 dbSNP
rs570411035 382 dbSNP
rs1215410615 385 dbSNP
rs9394955 387 dbSNP
rs9394956 390 dbSNP
rs1332703380 397 dbSNP
rs1324179023 399 dbSNP
rs997300698 400 dbSNP
rs983576444 403 dbSNP
rs537949866 405 dbSNP
rs116653268 407 dbSNP
rs1009702494 408 dbSNP
rs772690302 414 dbSNP
rs568253258 415 dbSNP
rs1247780272 418 dbSNP
rs1163489729 420 dbSNP
rs1366144216 421 dbSNP
rs1198828011 422 dbSNP
rs1342354967 433 dbSNP
rs1450534647 433 dbSNP
rs553632280 433 dbSNP
rs535682304 438 dbSNP
rs554087189 439 dbSNP
rs572328656 440 dbSNP
rs560770694 441 dbSNP
rs545845674 442 dbSNP
rs1426398260 445 dbSNP
rs932273713 449 dbSNP
rs1053464610 450 dbSNP
rs1235110614 454 dbSNP
rs1183666479 462 dbSNP
rs1483123323 464 dbSNP
rs1362944309 465 dbSNP
rs960694539 467 dbSNP
rs35888396 469 dbSNP
rs1443912948 471 dbSNP
rs558145114 472 dbSNP
rs116208590 473 dbSNP
rs1342734223 473 dbSNP
rs1042167776 483 dbSNP
rs906687945 491 dbSNP
rs1323573072 493 dbSNP
rs1306400323 494 dbSNP
rs115202991 497 dbSNP
rs1273718357 498 dbSNP
rs1048864196 501 dbSNP
rs1333850584 502 dbSNP
rs1413154952 505 dbSNP
rs1464308322 514 dbSNP
rs1160601443 520 dbSNP
rs542290673 524 dbSNP
rs895414398 529 dbSNP
rs371630009 530 dbSNP
rs994772449 544 dbSNP
rs116615275 547 dbSNP
rs1237726230 549 dbSNP
rs950774577 554 dbSNP
rs1253548090 561 dbSNP
rs1165389881 563 dbSNP
rs1425018532 563 dbSNP
rs1269909637 565 dbSNP
rs1005367649 566 dbSNP
rs901549151 566 dbSNP
rs997145167 570 dbSNP
rs1166337548 571 dbSNP
rs1019066245 573 dbSNP
rs1052862538 574 dbSNP
rs185510840 576 dbSNP
rs559761432 584 dbSNP
rs1010165977 586 dbSNP
rs976623203 586 dbSNP
rs921155777 588 dbSNP
rs953964720 608 dbSNP
rs931138006 612 dbSNP
rs989422970 617 dbSNP
rs1456064152 619 dbSNP
rs563152670 623 dbSNP
rs1387094817 626 dbSNP
rs1156261338 631 dbSNP
rs914897940 633 dbSNP
rs945095755 634 dbSNP
rs978244072 642 dbSNP
rs549334457 643 dbSNP
rs1447655672 646 dbSNP
rs1249724636 650 dbSNP
rs927742268 652 dbSNP
rs1464337042 656 dbSNP
rs1258926792 657 dbSNP
rs1223806285 659 dbSNP
rs1381499641 660 dbSNP
rs138957492 663 dbSNP
rs1226874652 664 dbSNP
rs1055239090 677 dbSNP
rs919355559 678 dbSNP
rs1434863223 682 dbSNP
rs895342195 689 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Disease 93643.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1 ...

- Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' gcUGGUACCGACAUCUGACAAu 5'
            ||| ||||| ||||||||| 
Target 5' caACCUUGGCUCUAGACUGUUa 3'
11 - 32
Article - Kishore S; Jaskiewicz L; Burger L; Hausser et al.
- Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions HEK293T
Disease 93643.0
Location of target site 3'UTR
Original Description (Extracted from the article) ... "Identi茂卢聛cation of Previously Unrecognized miR-132 Targets ...

- Cambronne XA; Shen R; Auer PL; Goodman RH, 2012, Proceedings of the National Academy of Sciences of the United States of America.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' gcUGGUACCGACAUCUGACAAu 5'
            ||| ||||| ||||||||| 
Target 5' caACCUUGGCUCUAGACUGUUa 3'
1 - 22
Article - Cambronne XA; Shen R; Auer PL; Goodman RH
- Proceedings of the National Academy of Sciences of the United States of America, 2012
Identifying targets is critical for understanding the biological effects of microRNA (miRNA) expression. The challenge lies in characterizing the cohort of targets for a specific miRNA, especially when targets are being actively down-regulated in miRNA- RNA-induced silencing complex (RISC)-messengerRNA (mRNA) complexes. We have developed a robust and versatile strategy called RISCtrap to stabilize and purify targets from this transient interaction. Its utility was demonstrated by determining specific high-confidence target datasets for miR-124, miR-132, and miR-181 that contained known and previously unknown transcripts. Two previously unknown miR-132 targets identified with RISCtrap, adaptor protein CT10 regulator of kinase 1 (CRK1) and tight junction-associated protein 1 (TJAP1), were shown to be endogenously regulated by miR-132 in adult mouse forebrain. The datasets, moreover, differed in the number of targets and in the types and frequency of microRNA recognition element (MRE) motifs, thus revealing a previously underappreciated level of specificity in the target sets regulated by individual miRNAs.
LinkOut: [PMID: 23184980]
Experimental Support 3 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HCT116
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1 PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1 PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1 ...

- Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research.

Article - Krell J; Stebbing J; Carissimi C; Dabrowska et al.
- Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
CLIP-seq Support 1 for dataset GSM714644
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repA
Location of target site ENST00000372444.2 | 3UTR | CCCCCACUCCCAACCUUGGCUCUAGACUGUUACUCUUAAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE42095 Differentiated embryonic stem cells -0.656 3.4e-4 -0.375 3.9e-2 23 Click to see details
GSE34608 Pulmonary tuberculosis and sarcoidosis -0.592 3.0e-3 -0.662 7.4e-4 20 Click to see details
GSE26953 Aortic valvular endothelial cells -0.538 3.3e-3 -0.553 2.5e-3 24 Click to see details
GSE28544 Breast cancer -0.409 2.4e-2 -0.338 5.3e-2 24 Click to see details
GSE21849 B cell lymphoma -0.278 7.2e-2 -0.149 2.2e-1 29 Click to see details
GSE17306 Multiple myeloma 0.192 9.3e-2 0.267 3.2e-2 49 Click to see details
GSE21687 Ependynoma primary tumors -0.149 1.2e-1 0.111 1.9e-1 64 Click to see details
GSE19783 ER+ ER+ breast cancer -0.265 1.3e-1 -0.371 5.4e-2 20 Click to see details
GSE38226 Liver fibrosis 0.217 1.7e-1 0.182 2.1e-1 21 Click to see details
GSE14794 Lymphoblastoid cells -0.091 2.0e-1 -0.134 1.0e-1 90 Click to see details
GSE35602 Colorectal cancer stromal tissue -0.171 2.1e-1 -0.048 4.1e-1 25 Click to see details
GSE17498 Multiple myeloma 0.116 2.4e-1 0.134 2.0e-1 40 Click to see details
GSE38974 Chronic obstructive pulmonary disease -0.134 2.6e-1 -0.189 1.8e-1 25 Click to see details
GSE15076 Monocyte-derived dendritic cells 0.213 2.9e-1 0.033 4.7e-1 9 Click to see details
GSE21032 Prostate cancer -0.059 3.0e-1 -0.035 3.8e-1 83 Click to see details
GSE32688 Pancreatic cancer -0.055 3.8e-1 0.200 1.4e-1 32 Click to see details
GSE27834 Pluripotent stem cells -0.073 3.9e-1 0.018 4.7e-1 16 Click to see details
GSE19536 Breast cancer 0.016 4.4e-1 0.005 4.8e-1 100 Click to see details
GSE19783 ER- ER- breast cancer 0.014 4.5e-1 0.048 3.4e-1 79 Click to see details
GSE28260 Renal cortex and medulla -0.035 4.5e-1 -0.214 2.4e-1 13 Click to see details
GSE19350 CNS germ cell tumors -0.025 4.7e-1 -0.056 4.3e-1 12 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
KIRP -0.393 0.01 -0.268 0.07 32 Click to see details
BLCA -0.494 0.02 -0.478 0.02 18 Click to see details
PAAD -0.845 0.08 -1.000 0.5 4 Click to see details
PRAD 0.188 0.1 0.125 0.19 50 Click to see details
ESCA -0.394 0.12 -0.355 0.14 11 Click to see details
CHOL 0.429 0.12 0.483 0.09 9 Click to see details
STAD -0.196 0.14 -0.217 0.12 32 Click to see details
PCPG -0.884 0.15 -1.000 0.5 3 Click to see details
HNSC 0.155 0.16 0.130 0.21 42 Click to see details
COAD -0.316 0.22 -0.095 0.41 8 Click to see details
LUAD -0.231 0.24 -0.217 0.25 12 Click to see details
KICH 0.151 0.24 0.154 0.23 25 Click to see details
UCEC 0.145 0.28 0.037 0.44 19 Click to see details
KIRC -0.06 0.31 -0.160 0.1 68 Click to see details
LIHC 0.066 0.33 -0.022 0.44 49 Click to see details
CESC 0.48 0.34 0.500 0.33 3 Click to see details
BRCA 0.028 0.4 -0.013 0.45 84 Click to see details
LUSC -0.03 0.43 -0.079 0.32 38 Click to see details
THCA 0.012 0.46 0.116 0.19 59 Click to see details
THCA 0.012 0.46 0.116 0.19 59 Click to see details
THCA 0.012 0.46 0.116 0.19 59 Click to see details
247 hsa-miR-132-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000333 SIRT1 sirtuin 1 4 1
MIRT000334 MECP2 methyl-CpG binding protein 2 1 1
MIRT000601 CDKN1A cyclin dependent kinase inhibitor 1A 4 1
MIRT002329 RFX4 regulatory factor X4 1 1
MIRT003926 ARHGAP32 Rho GTPase activating protein 32 4 3
MIRT006503 RB1 RB transcriptional corepressor 1 5 1
MIRT006628 Mecp2 methyl CpG binding protein 2 4 1
MIRT006659 HBEGF heparin binding EGF like growth factor 4 3
MIRT007010 RASA1 RAS p21 protein activator 1 1 1
MIRT007166 CRK CRK proto-oncogene, adaptor protein 2 2
MIRT007167 TJAP1 tight junction associated protein 1 3 3
MIRT007253 TLN2 talin 2 1 2
MIRT021716 ARL6IP6 ADP ribosylation factor like GTPase 6 interacting protein 6 1 1
MIRT021717 COX8C cytochrome c oxidase subunit 8C 1 1
MIRT021718 PIP5K1A phosphatidylinositol-4-phosphate 5-kinase type 1 alpha 1 1
MIRT021719 CDH3 cadherin 3 1 1
MIRT021720 LOXL1 lysyl oxidase like 1 1 1
MIRT021721 TNFRSF17 TNF receptor superfamily member 17 1 1
MIRT021722 ADH1A alcohol dehydrogenase 1A (class I), alpha polypeptide 1 1
MIRT021723 KCTD4 potassium channel tetramerization domain containing 4 1 1
MIRT021724 PROSC pyridoxal phosphate binding protein 1 1
MIRT021725 WNT3A Wnt family member 3A 1 1
MIRT021726 KCNJ9 potassium voltage-gated channel subfamily J member 9 1 1
MIRT021727 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 1 1
MIRT021728 KIR3DL1 killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 1 1
MIRT021729 ARF6 ADP ribosylation factor 6 1 1
MIRT021730 PLSCR1 phospholipid scramblase 1 1 1
MIRT021731 CSTF2T cleavage stimulation factor subunit 2 tau variant 1 1
MIRT021732 TAF15 TATA-box binding protein associated factor 15 1 1
MIRT021733 NR1D2 nuclear receptor subfamily 1 group D member 2 1 1
MIRT021734 EPHA4 EPH receptor A4 1 1
MIRT021735 RTEL1-TNFRSF6B RTEL1-TNFRSF6B readthrough (NMD candidate) 1 1
MIRT021736 MUC17 mucin 17, cell surface associated 1 1
MIRT021737 CA1 carbonic anhydrase 1 1 1
MIRT021738 S100A1 S100 calcium binding protein A1 1 1
MIRT021739 FKBP10 FK506 binding protein 10 1 1
MIRT021740 PLA2G4C phospholipase A2 group IVC 1 1
MIRT021741 GSTCD glutathione S-transferase C-terminal domain containing 1 1
MIRT021742 LIG4 DNA ligase 4 1 1
MIRT021743 POLK DNA polymerase kappa 1 1
MIRT021744 STMN1 stathmin 1 1 1
MIRT021745 DMGDH dimethylglycine dehydrogenase 1 1
MIRT021746 MLLT10 MLLT10, histone lysine methyltransferase DOT1L cofactor 1 1
MIRT021747 TRIM36 tripartite motif containing 36 1 1
MIRT021748 EOGT EGF domain specific O-linked N-acetylglucosamine transferase 1 1
MIRT021749 ANKRD28 ankyrin repeat domain 28 1 1
MIRT021750 GCNT1 glucosaminyl (N-acetyl) transferase 1, core 2 1 1
MIRT021751 PTPLAD1 3-hydroxyacyl-CoA dehydratase 3 1 1
MIRT021752 SSR3 signal sequence receptor subunit 3 1 1
MIRT021753 KBTBD3 kelch repeat and BTB domain containing 3 1 1
MIRT021754 SYT14 synaptotagmin 14 1 1
MIRT021755 MAP1B microtubule associated protein 1B 1 1
MIRT021756 YKT6 YKT6 v-SNARE homolog 1 1
MIRT021757 CD55 CD55 molecule (Cromer blood group) 1 1
MIRT021758 AASDHPPT aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase 1 1
MIRT021759 UBE2W ubiquitin conjugating enzyme E2 W 1 1
MIRT021760 GBAS nipsnap homolog 2 1 1
MIRT021761 TMEM47 transmembrane protein 47 1 1
MIRT021762 BNIP2 BCL2 interacting protein 2 1 1
MIRT021763 ZNF652 zinc finger protein 652 1 1
MIRT021764 FAM199X family with sequence similarity 199, X-linked 1 1
MIRT021765 FAM81A family with sequence similarity 81 member A 1 1
MIRT021766 CHRNA5 cholinergic receptor nicotinic alpha 5 subunit 1 1
MIRT021767 FRY FRY microtubule binding protein 1 1
MIRT021768 PTGS2 prostaglandin-endoperoxide synthase 2 1 1
MIRT021769 TUSC2 tumor suppressor candidate 2 1 1
MIRT021770 OSBPL8 oxysterol binding protein like 8 1 1
MIRT021771 CTDSPL2 CTD small phosphatase like 2 1 1
MIRT021772 MEF2A myocyte enhancer factor 2A 1 1
MIRT021773 PSMD12 proteasome 26S subunit, non-ATPase 12 1 1
MIRT021774 SPAST spastin 1 1
MIRT021775 ATP6V0E1 ATPase H+ transporting V0 subunit e1 1 1
MIRT021776 PRSS22 protease, serine 22 1 1
MIRT021777 SH3BGRL SH3 domain binding glutamate rich protein like 1 1
MIRT021778 KRT6C keratin 6C 1 1
MIRT021779 CST9L cystatin 9 like 1 1
MIRT021780 EBPL emopamil binding protein like 1 1
MIRT021781 SYNE3 spectrin repeat containing nuclear envelope family member 3 1 1
MIRT021782 FAM221B family with sequence similarity 221 member B 1 1
MIRT021783 GATA3 GATA binding protein 3 1 1
MIRT021784 EMILIN3 elastin microfibril interfacer 3 1 1
MIRT021785 ARL13B ADP ribosylation factor like GTPase 13B 1 1
MIRT021786 CYP26A1 cytochrome P450 family 26 subfamily A member 1 1 1
MIRT021787 SAMSN1 SAM domain, SH3 domain and nuclear localization signals 1 1 1
MIRT021788 GNL3L G protein nucleolar 3 like 1 1
MIRT021789 ETNK2 ethanolamine kinase 2 1 1
MIRT021790 DEPDC7 DEP domain containing 7 1 1
MIRT021791 FGF22 fibroblast growth factor 22 1 1
MIRT021792 FUT1 fucosyltransferase 1 (H blood group) 1 1
MIRT021793 KRTAP4-11 keratin associated protein 4-11 1 1
MIRT021794 SEC61A1 Sec61 translocon alpha 1 subunit 1 1
MIRT021795 CR2 complement C3d receptor 2 1 1
MIRT021796 MMP13 matrix metallopeptidase 13 1 1
MIRT021797 SYNDIG1L synapse differentiation inducing 1 like 1 1
MIRT021798 TFPI tissue factor pathway inhibitor 1 1
MIRT021799 RNF128 ring finger protein 128, E3 ubiquitin protein ligase 1 1
MIRT021800 SFXN2 sideroflexin 2 1 1
MIRT021801 PSMA2 proteasome subunit alpha 2 3 5
MIRT021802 FABP7 fatty acid binding protein 7 1 1
MIRT021803 CNTNAP1 contactin associated protein 1 1 1
MIRT021804 FBN3 fibrillin 3 1 1
MIRT021805 KIR3DL2 killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2 1 1
MIRT021806 LFNG LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase 1 1
MIRT021807 B3GAT1 beta-1,3-glucuronyltransferase 1 1 1
MIRT021808 ARR3 arrestin 3 1 1
MIRT021809 GK glycerol kinase 1 1
MIRT021810 SMN1 survival of motor neuron 1, telomeric 1 1
MIRT021811 ALK ALK receptor tyrosine kinase 1 1
MIRT021812 PRX periaxin 1 1
MIRT021813 CYP2E1 cytochrome P450 family 2 subfamily E member 1 1 1
MIRT021814 ADAMTSL1 ADAMTS like 1 1 1
MIRT021815 NCS1 neuronal calcium sensor 1 1 1
MIRT021816 CFTR cystic fibrosis transmembrane conductance regulator 1 1
MIRT021817 OAS2 2'-5'-oligoadenylate synthetase 2 1 1
MIRT021818 C8orf33 chromosome 8 open reading frame 33 1 1
MIRT021819 FAT4 FAT atypical cadherin 4 1 1
MIRT021820 GPR115 adhesion G protein-coupled receptor F4 1 1
MIRT021821 ZDHHC2 zinc finger DHHC-type containing 2 1 1
MIRT021822 INTS8 integrator complex subunit 8 1 1
MIRT021823 IMPA1 inositol monophosphatase 1 1 1
MIRT021824 FAT3 FAT atypical cadherin 3 1 1
MIRT021825 VPS13D vacuolar protein sorting 13 homolog D 1 1
MIRT021826 DOCK10 dedicator of cytokinesis 10 1 1
MIRT021827 LCA5 LCA5, lebercilin 1 1
MIRT021828 ARL14EP ADP ribosylation factor like GTPase 14 effector protein 1 1
MIRT021829 MTMR10 myotubularin related protein 10 1 1
MIRT021830 TRIM23 tripartite motif containing 23 1 1
MIRT021831 CHL1 cell adhesion molecule L1 like 1 1
MIRT021832 NDUFB10 NADH:ubiquinone oxidoreductase subunit B10 1 1
MIRT021833 NBN nibrin 1 1
MIRT021834 THBS1 thrombospondin 1 1 1
MIRT021835 GJE1 gap junction protein epsilon 1 1 1
MIRT021836 SNX7 sorting nexin 7 1 1
MIRT021837 EYA4 EYA transcriptional coactivator and phosphatase 4 1 1
MIRT021838 CASP7 caspase 7 1 1
MIRT021839 ECT2 epithelial cell transforming 2 1 1
MIRT021840 EXOC5 exocyst complex component 5 1 1
MIRT021841 CD164 CD164 molecule 1 1
MIRT021842 STAU1 staufen double-stranded RNA binding protein 1 1 1
MIRT021843 ANKRD29 ankyrin repeat domain 29 1 1
MIRT021844 CCSER2 coiled-coil serine rich protein 2 1 1
MIRT021845 RTN4 reticulon 4 1 1
MIRT021846 MDFIC MyoD family inhibitor domain containing 1 1
MIRT021847 ZNF236 zinc finger protein 236 1 1
MIRT021848 SDF2 stromal cell derived factor 2 1 1
MIRT021849 SPRED1 sprouty related EVH1 domain containing 1 1 1
MIRT021850 CMTM3 CKLF like MARVEL transmembrane domain containing 3 1 1
MIRT021851 MAP3K3 mitogen-activated protein kinase kinase kinase 3 1 1
MIRT021852 ACTR2 ARP2 actin related protein 2 homolog 1 1
MIRT021853 NAP1L1 nucleosome assembly protein 1 like 1 1 1
MIRT021854 FBXO28 F-box protein 28 1 1
MIRT021855 LGR4 leucine rich repeat containing G protein-coupled receptor 4 1 1
MIRT021856 ZNF148 zinc finger protein 148 1 1
MIRT021857 TBC1D9 TBC1 domain family member 9 1 1
MIRT021858 VDAC2 voltage dependent anion channel 2 1 1
MIRT021859 CC2D1B coiled-coil and C2 domain containing 1B 1 1
MIRT021860 MUC13 mucin 13, cell surface associated 1 1
MIRT021861 TSPAN6 tetraspanin 6 1 1
MIRT021862 GTF2H1 general transcription factor IIH subunit 1 1 1
MIRT021863 CALU calumenin 1 1
MIRT021864 CAMSAP2 calmodulin regulated spectrin associated protein family member 2 1 1
MIRT021865 CCNA2 cyclin A2 2 1
MIRT021866 CCNB1 cyclin B1 2 1
MIRT045838 PARP10 poly(ADP-ribose) polymerase family member 10 1 1
MIRT045839 RPL7 ribosomal protein L7 1 1
MIRT045840 FOXO1 forkhead box O1 4 2
MIRT045841 GNB2L1 receptor for activated C kinase 1 1 1
MIRT045842 CSTF3 cleavage stimulation factor subunit 3 1 1
MIRT045843 RPSA ribosomal protein SA 1 1
MIRT045844 ANXA2 annexin A2 1 1
MIRT045845 NCKAP1 NCK associated protein 1 1 1
MIRT045846 RPS5 ribosomal protein S5 1 1
MIRT045847 IRAK1 interleukin 1 receptor associated kinase 1 1 1
MIRT045848 PDLIM7 PDZ and LIM domain 7 1 1
MIRT054502 BDNF brain derived neurotrophic factor 2 1
MIRT054835 HN1 Jupiter microtubule associated homolog 1 4 1
MIRT054836 KLHL11 kelch like family member 11 4 1
MIRT054837 MAPK1 mitogen-activated protein kinase 1 4 1
MIRT054894 SOX5 SRY-box 5 2 1
MIRT091255 FXR1 FMR1 autosomal homolog 1 2 4
MIRT100367 HSPA1B heat shock protein family A (Hsp70) member 1B 2 2
MIRT106174 RRS1 ribosome biogenesis regulator homolog 2 2
MIRT149855 LDLR low density lipoprotein receptor 2 2
MIRT217679 ASF1A anti-silencing function 1A histone chaperone 2 2
MIRT259587 EIF2S3 eukaryotic translation initiation factor 2 subunit gamma 2 2
MIRT289307 TNRC6C trinucleotide repeat containing 6C 2 2
MIRT368374 ARID2 AT-rich interaction domain 2 2 2
MIRT438882 IRAK4 interleukin 1 receptor associated kinase 4 1 1
MIRT442189 HOOK3 hook microtubule tethering protein 3 2 2
MIRT449483 STAG1 stromal antigen 1 2 2
MIRT453131 HOXC4 homeobox C4 2 2
MIRT455372 KDM5C lysine demethylase 5C 2 2
MIRT455526 C6orf106 chromosome 6 open reading frame 106 2 2
MIRT458882 PFAS phosphoribosylformylglycinamidine synthase 2 2
MIRT464180 VMP1 vacuole membrane protein 1 2 21
MIRT467690 SLC38A2 solute carrier family 38 member 2 2 4
MIRT476656 FZD6 frizzled class receptor 6 2 4
MIRT477439 EML4 echinoderm microtubule associated protein like 4 2 4
MIRT479294 CHAC1 ChaC glutathione specific gamma-glutamylcyclotransferase 1 2 2
MIRT485291 PLAGL2 PLAG1 like zinc finger 2 2 2
MIRT495258 BMPER BMP binding endothelial regulator 2 2
MIRT497153 PRDM15 PR/SET domain 15 2 2
MIRT500830 TCEB1 elongin C 2 2
MIRT506948 HS3ST3B1 heparan sulfate-glucosamine 3-sulfotransferase 3B1 2 4
MIRT507623 CRTC1 CREB regulated transcription coactivator 1 2 2
MIRT508137 AMD1 adenosylmethionine decarboxylase 1 2 2
MIRT526271 CCDC169 coiled-coil domain containing 169 2 2
MIRT526867 PARP11 poly(ADP-ribose) polymerase family member 11 2 2
MIRT532420 ART4 ADP-ribosyltransferase 4 (Dombrock blood group) 2 2
MIRT532508 TWISTNB TWIST neighbor 2 4
MIRT534833 RAB18 RAB18, member RAS oncogene family 2 2
MIRT542577 ZNF280B zinc finger protein 280B 2 2
MIRT546160 TSPAN12 tetraspanin 12 2 2
MIRT547255 NUP50 nucleoporin 50 2 4
MIRT547614 LIFR LIF receptor alpha 2 2
MIRT547705 KPNA1 karyopherin subunit alpha 1 2 4
MIRT549141 BRWD1 bromodomain and WD repeat domain containing 1 2 2
MIRT549455 ACSL4 acyl-CoA synthetase long chain family member 4 2 2
MIRT551640 TRUB1 TruB pseudouridine synthase family member 1 2 4
MIRT554985 RAB5B RAB5B, member RAS oncogene family 2 2
MIRT555924 OCLN occludin 5 4
MIRT557610 GNB1 G protein subunit beta 1 2 2
MIRT571512 ZNF711 zinc finger protein 711 2 2
MIRT572928 PRAMEF1 PRAME family member 1 2 2
MIRT573617 ZNF724P zinc finger protein 724 2 2
MIRT574924 Vmp1 vacuole membrane protein 1 2 12
MIRT614465 ALKBH4 alkB homolog 4, lysine demethylase 2 2
MIRT623025 OLFML2A olfactomedin like 2A 2 2
MIRT639080 CD226 CD226 molecule 2 2
MIRT642134 CYP20A1 cytochrome P450 family 20 subfamily A member 1 2 2
MIRT653734 SLC25A32 solute carrier family 25 member 32 2 2
MIRT655167 PHF20L1 PHD finger protein 20 like 1 2 2
MIRT680989 DCAF17 DDB1 and CUL4 associated factor 17 2 2
MIRT681564 UBXN2A UBX domain protein 2A 2 2
MIRT696294 IER3IP1 immediate early response 3 interacting protein 1 2 2
MIRT697724 USP8 ubiquitin specific peptidase 8 2 2
MIRT703296 GID4 GID complex subunit 4 homolog 2 2
MIRT718422 CALN1 calneuron 1 2 2
MIRT719460 APBA1 amyloid beta precursor protein binding family A member 1 2 2
MIRT731713 EGFR epidermal growth factor receptor 3 1
MIRT731714 RAF1 Raf-1 proto-oncogene, serine/threonine kinase 3 1
MIRT732779 ZEB2 zinc finger E-box binding homeobox 2 2 0
MIRT732980 GSK3B glycogen synthase kinase 3 beta 3 0
MIRT734466 HDAC3 histone deacetylase 3 2 0
MIRT734880 FOXO3 forkhead box O3 3 0
MIRT735319 SNHG16 small nucleolar RNA host gene 16 2 0
MIRT755706 BNC2 basonuclin 2 1 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-132 5-aza-2'-deoxycytidine (5-Aza-CdR) + 4-phenylbutyric acid (PBA) NULL NULL Microarray T24 human bladder cancer cells 16766263 2006 up-regulated
miR-132 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 up-regulated
miR-132 Gemcitabine approved 60750 Microarray ovarian cancer 19237188 2009 down-regulated
miR-132 Vorinostat (SAHA) approved 5311 Microarray A549 human non-small cell lung cancer cells 19513533 2009 up-regulated
miR-132 Morphine approved 5288826 Microarray human monocyte-derived macrophages (h-mdms) infection with HIV-1 20564181 2010 up-regulated
miR-132 Arsenic trioxide approved 14888 Quantitative real-time PCR acute promyelocytic leukemia 22072212 2012 up-regulated
miR-132 1,2,6-Tri-O-galloyl-beta-D-glucopyranose NULL NULL Microarray HepG2 hepatocarcinoma cells. 22506400 2011 down-regulated
miR-132 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miR-132 Luteolin NULL 5280445 Quantitative real-time PCR PC12 cells 22916239 2012 up-regulated
miR-132 ACTH approved 16132265 Quantitative real-time PCR adrenals and granulosa cells 24205079 2014 up-regulated
miR-132 1,2,6-Tri-O-galloyl-beta-D-glucopyranose NULL NULL Microarray HepG2 hepatocarcinoma cells. 22506400 2011 down-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-132 Cisplatin 5460033 NSC119875 approved resistant High Ovarian Cancer cell line (A2780CP20)
hsa-mir-132 Cisplatin 5460033 NSC119875 approved resistant cell line (CP20)
hsa-mir-132 Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-mir-132 Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-mir-132 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-132 Cisplatin 5460033 NSC119875 approved sensitive cell line (BxPC3)
hsa-mir-132 Ceritinib 57379345 NSC776422 approved sensitive cell line (H3122)
hsa-miR-132-3p (1Z)-2-anilino-N-[(5-carbamoyl-1H-imidazol-4-yl)amino]-2-oxoethanimidoyl cyanide 5466279 NSC683605 resistant
hsa-miR-132-3p (2Z)-2-(tert-butylhydrazinylidene)-N-(3-chloro-1,4-dioxonaphthalen-2-yl)-3-(3,7,12-trioxo-4H-naphtho[2,3-h]quinoxalin-2-yl)propanamide 5479912 NSC649574 resistant
hsa-miR-132-3p (7-acetamido-2-acetyloxy-1-methoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-3-yl) acetate 435732 NSC374980 sensitive
hsa-miR-132-3p (e)-1-(benzenesulfonyl)-3-(2-phenyl-1h-indol-3-yl)prop-2-en-1-one 54613416 NSC749193 sensitive
hsa-miR-132-3p (E)-3-[3,5-bis(trifluoromethyl)phenyl]sulfanyl-1-(4-chlorophenyl)prop-2-en-1-one 6181983 NSC735169 resistant
hsa-miR-132-3p (Z)-3-[5-[3,5-bis(trifluoromethyl)phenyl]furan-2-yl]prop-2-enenitrile 5468615 NSC672868 sensitive
hsa-miR-132-3p (z)-6-(2-(pyridin-2-ylmethylene)hydrazinyl)-9h-purine 60147744 NSC752329 resistant
hsa-miR-132-3p [(5s,8ar,9r)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5h-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl] 3-aminobenzoate NSC642276 sensitive
hsa-miR-132-3p [3,4,5-triacetyloxy-6-(3-cyano-6-phenyl-2-sulfanyl-4-thiophen-2-yl-4h-pyridin-1-yl)oxan-2-yl]methyl acetate 381303 NSC667740 sensitive
hsa-miR-132-3p 1-(2-thiazoylazo)-2-naphthol 93572 NSC139021 resistant
hsa-miR-132-3p 1-(4-methoxyphenyl)-3-[(z)-1-[6-[(z)-n-[(4-methoxyphenyl)carbamothioylamino]-c-methylcarbonimidoyl]pyridin-2-yl]ethylideneamino]thiourea 6375828 NSC668486 resistant
hsa-miR-132-3p 1-(6,7-dichloro-1-(4-chlorophenyl)-1h-pyrazolo[3,4-b]quinoxalin-3-yl)-1,2,3,4-butanetetrol 365567 NSC633362 sensitive
hsa-miR-132-3p 1-(acetyloxy)-2-(2-(1-(acetyloxy)-1h-benzimidazol-2-yl)phenyl)-1h-benzimidazole 355531 NSC609356 sensitive
hsa-miR-132-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 sensitive
hsa-miR-132-3p 10-nitrosophenanthren-9-ol 95223 NSC48526 sensitive
hsa-miR-132-3p 12-imino-4,10,14,20-tetrazapentacyclo[11.7.0.03,11.04,9.014,19]icosa-1(13),3(11),9,19-tetraen-2-one 46861729 NSC753790 sensitive
hsa-miR-132-3p 15-benzyl-9-pyridin-3-yl-15-azatetracyclo[8.6.1.02,7.014,17]heptadeca-1(16),2,4,6,10(17),11,13-heptaen-8-one 57409953 NSC762458 sensitive
hsa-miR-132-3p 2-((5-methyl-3-isoxazolyl)amino)-4-((5-methyl-3-isoxazolyl)imino)-1(4h)-naphthalenone 373420 NSC649750 sensitive
hsa-miR-132-3p 2-(3-chloropropyloxy)naphthazarin 378771 NSC661941 sensitive
hsa-miR-132-3p 2-(4-methylphenyl)-5-phenyl-1h-[1,2,4]triazino[4,3-a]quinoxaline 399104 NSC709520 resistant
hsa-miR-132-3p 2-(6-benzoyl-1h-benzimidazol-2-yl)-3,4,5,6-tetrachloro-n-(furan-2-yl)benzamide 402231 NSC716122 sensitive
hsa-miR-132-3p 2-(diethylamino)ethyl (E)-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)prop-2-enoate 5388753 NSC638408 sensitive
hsa-miR-132-3p 2-(furan-2-yl)-5-phenyl-1h-pyrazolo[1,5-a]pyrimidin-7-one 342597 NSC379651 sensitive
hsa-miR-132-3p 2-[(e)-[[1-(4-chlorophenyl)-3-methylpyrazolo[3,4-d]pyrimidin-4-yl]hydrazinylidene]methyl]phenol 136040127 NSC753018 resistant
hsa-miR-132-3p 2-[(z)-6-[2-(trifluoromethyl)phenyl]hex-3-en-1,5-diynyl]aniline 24203959 NSC730269 sensitive
hsa-miR-132-3p 2-amino-4-cyclopropyl-6-(4-fluorophenyl)cyclohexa-2,4-diene-1,1,3-tricarbonitrile 400138 NSC711632 sensitive
hsa-miR-132-3p 2-amino-9-chloro-3,5-bis(4-chlorophenyl)pyrimido[4,5-c]quinolin-1-one 16126264 NSC741296 resistant
hsa-miR-132-3p 2-amino-N-[4-chloro-2-(1H-pyrrole-2-carbonyl)phenyl]acetamide 284708 NSC140873 sensitive
hsa-miR-132-3p 2-bromo-1-[6-(2-bromopyridin-1-ium-1-yl)naphthalen-2-yl]pyridin-1-ium;bromide 54608313 NSC129757 resistant
hsa-miR-132-3p 2-methoxy-5h-pyrido[3,2:4,5]pyrrolo[3,2-c]cinnoline 54613488 NSC749296 resistant
hsa-miR-132-3p 2-methylthieno[3,2-f][1]benzothiole-4,8-dione 375901 NSC656238 sensitive
hsa-miR-132-3p 2-nitro-3-phenylspiro[cyclopropane-1,9'-fluorene] 282082 NSC135168 sensitive
hsa-miR-132-3p 2-oxo-n-(pyridin-4-yl)-2-(1-tosyl-1h-indol-3-yl)acetamide 155814544 NSC758357 sensitive
hsa-miR-132-3p 2,3,10,11-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-8-one 392605 NSC693145 resistant
hsa-miR-132-3p 2,5,11-trimethyl-9-phenoxy-6h-pyrido[4,3-b]carbazol-2-ium;acetate 10431819 NSC650269 sensitive
hsa-miR-132-3p 2,6-bis[1-(3-ethylthioureidoimino)ethyl]pyridine 6393657 NSC668337 resistant
hsa-miR-132-3p 3-(3,5-dibromo-4-methoxyphenyl)-2-(3-pyridinyl)acrylonitrile 5467796 NSC659319 sensitive
hsa-miR-132-3p 3-(3,5-dichlorophenyl)-2-(2-pyridinyl)acrylonitrile 5467799 NSC659323 sensitive
hsa-miR-132-3p 3-[(2,3-dimethoxyphenyl)methyl]-7,8-dimethoxy-5-methylsulfanyl-2,5-dihydro-1H-3-benzazepin-4-one 359177 NSC619859 sensitive
hsa-miR-132-3p 3-[(E)-[(4-nitrophenyl)hydrazinylidene]methyl]-1H-benzo[g]quinoxaline-2,5,10-trione 135436193 NSC713198 sensitive
hsa-miR-132-3p 3-[(Z)-[1-(3,4,5-trimethoxyphenyl)pyrido[3,4-b]indol-3-ylidene]methyl]-1H-indol-2-ol 155808310 NSC761816 sensitive
hsa-miR-132-3p 3-[(Z)-[1-(3,5-dimethoxyphenyl)pyrido[3,4-b]indol-3-ylidene]methyl]-5-methoxy-1H-indol-2-ol 155813091 NSC761832 sensitive
hsa-miR-132-3p 3-[[3-(furan-2-carbonyl)-2-sulfanylideneimidazolidin-1-yl]methylidene]pentane-2,4-dione 24203787 NSC729519 resistant
hsa-miR-132-3p 3-[5-(4-amino-2,6-dibromophenyl)-1,3,4-oxadiazol-2-yl]-1-(1H-benzimidazol-2-yl)propan-1-one 71451481 NSC761980 sensitive
hsa-miR-132-3p 3-[6-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)hexyl]-5,5-diphenylimidazolidine-2,4-dione 343242 NSC382386 sensitive
hsa-miR-132-3p 3-amino-N-(2-fluorophenyl)-5-oxo-7,8-dihydro-6H-thieno[2,3-b]quinoline-2-carboxamide 1856915 NSC754567 sensitive
hsa-miR-132-3p 4-(4,7-dimethoxy-1,3-benzodioxol-5-yl)-5-(4-methoxyphenyl)-2H-triazole 73334660 NSC763198 sensitive
hsa-miR-132-3p 4-[(13R)-13-hydroxy-13-[(2S,5S)-5-[(2S,5S)-5-[1-hydroxy-13-[(2S)-2-methyl-5-oxo-2H-furan-4-yl]tridecyl]oxolan-2-yl]oxolan-2-yl]tridecyl]-2-methyl-2H-furan-5-one 374064 NSC651320 sensitive
hsa-miR-132-3p 4-[(2Z)-2-[1-amino-3-(methylamino)-1,3-bis(sulfanylidene)propan-2-ylidene]hydrazinyl]-1H-imidazole-5-carboxamide 5466293 NSC684046 resistant
hsa-miR-132-3p 4-[(e)-(9-ethylcarbazol-3-yl)azo]benzonitrile 394667 NSC698269 sensitive
hsa-miR-132-3p 4-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]quinoline 6285127 NSC87197 sensitive
hsa-miR-132-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 sensitive
hsa-miR-132-3p 4-[[(Z)-N-benzamido-C-[4-[bis(2-cyanoethyl)amino]-2-methylphenyl]carbonimidoyl]diazenyl]benzoic acid 135493923 NSC681974 sensitive
hsa-miR-132-3p 4-[2-[2-(4-carbamimidoylanilino)ethoxy]ethylamino]benzenecarboximidamide;hydrochloride 24206088 NSC740025 sensitive
hsa-miR-132-3p 4-[4-(diethylamino)benzenecarboximidoyl]-n,n-dimethylaniline;hydrochloride NSC33566 sensitive
hsa-miR-132-3p 4-[4,6-bis(methylsulfanyl)pyrazolo[3,4-d]pyrimidin-1-yl]-7-chloroquinoline 24203467 NSC728188 sensitive
hsa-miR-132-3p 4-methylsulfanyl-N-[(3,4,5-trimethoxyphenyl)methyl]aniline 373808 NSC650772 sensitive
hsa-miR-132-3p 4-methylthio-n-(3,4,5-trimethoxybenzyl)aniline 373808 NSC650771 sensitive
hsa-miR-132-3p 4,5-bis(4-methoxyphenyl)-1h-imidazol-2(5h)-one 231112 NSC26692 sensitive
hsa-miR-132-3p 5-[2-(3-hydroxy-4-methoxyphenyl)ethynyl]-6-(3,4,5-trimethoxyphenyl)pyran-2-one 45028148 NSC741289 sensitive
hsa-miR-132-3p 5-bromo-3h-triazolo[4,5-d]pyrimidin-7-ol 135440019 NSC680827 resistant
hsa-miR-132-3p 5-hydroxy-10-methoxy-1-methylbenzo[g]quinolin-4(1h)-one 406554 NSC724702 sensitive
hsa-miR-132-3p 5-methylphenanthroline 72791 NSC4272 resistant
hsa-miR-132-3p 5,10-dimethoxybenzo[g]quinolin-2(1h)-one 54612875 NSC750104 sensitive
hsa-miR-132-3p 6-butyl-12-methyl-5,6-dihydrobenzimidazolo[2,1-a]isoquinolin-7-ium-3,10-diol;6-butyl-12-methyl-5,6-dihydrobenzimidazolo[2,1-a]isoquinolin-12-ium-3,9-diol;diiodide 403475 NSC718370 sensitive
hsa-miR-132-3p 7-[(1-hydroxy-1-phenylpropan-2-yl)amino]quinoline-5,8-dione 386231 NSC677949 sensitive
hsa-miR-132-3p 7-[(3,4-dimethoxyphenyl)methyl]-6-phenyl-4,5-dihydropyrrolo[3,4-g][1,2]benzoxazole 60148271 NSC754077 sensitive
hsa-miR-132-3p 8-azadenosine 251928 NSC72961 resistant
hsa-miR-132-3p 9-methyl-2-[4-(4-phenylpiperazin-1-yl)butyl]-3,4-dihydropyrido[3,4-b]indol-1-one 365677 NSC633530 sensitive
hsa-miR-132-3p Acetonitrile;carbon monoxide;dibromoosmium;triphenylphosphane 498712 NSC634761 resistant
hsa-miR-132-3p Antineoplastic-642316 369949 NSC642316 sensitive
hsa-miR-132-3p B1a8bpf5u8 72574 NSC84167 sensitive
hsa-miR-132-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 sensitive
hsa-miR-132-3p Benzyl 4-[(3,6-dioxocyclohexa-1,4-dien-1-yl)methylamino]benzoate 386492 NSC678636 resistant
hsa-miR-132-3p Bindschedler's green 73516 NSC7811 sensitive
hsa-miR-132-3p Chlorotriethyltin 13820 NSC5283 sensitive
hsa-miR-132-3p Chrome black t 3246023 NSC7223 resistant
hsa-miR-132-3p Cinnoline, 4-nitro-, 1-oxide 100397 NSC294846 resistant
hsa-miR-132-3p Dezaguanine 55710 NSC261726 resistant
hsa-miR-132-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 sensitive
hsa-miR-132-3p Dimethyl 1-[(z)-2-[(z)-1,4-dimethoxy-1,4-dioxobut-2-en-2-yl]sulfanyl-1,2-bis(4-methoxyphenyl)ethenyl]pyrazole-3,4-dicarboxylate 5471659 NSC712735 resistant
hsa-miR-132-3p Erlotinib 176870 NSC718781 approved resistant
hsa-miR-132-3p Ethanol, 2-[4-(2,2':6',2"-terpyridin-4'-yl)phenoxy]- 368990 NSC640499 resistant
hsa-miR-132-3p Ethanone, 1-(2-pyrimidinyl)-, (2-benzoxazolyl)hydrazone 9572051 NSC693639 resistant
hsa-miR-132-3p Ethaverine hydrochloride 5702159 NSC757818 sensitive
hsa-miR-132-3p Fluorene, 9-bromo-2,4,7-trichloro- 248608 NSC65921 sensitive
hsa-miR-132-3p Gardenin b 96539 NSC79093 sensitive
hsa-miR-132-3p Gw693881a 44571452 NSC756316 resistant
hsa-miR-132-3p Hedamycin 98033 NSC70929 sensitive
hsa-miR-132-3p Hymenialdisine 135413546 NSC607173 resistant
hsa-miR-132-3p Ls-94160 135408599 NSC52426 resistant
hsa-miR-132-3p Megxp0_000612 5386961 NSC618932 resistant
hsa-miR-132-3p Methyl (1s,10r)-6-methyl-10-nonyl-7,9,12-triazatricyclo[6.3.1.04,12]dodeca-5,8-diene-5-carboxylate 401693 NSC715423 sensitive
hsa-miR-132-3p Methyl (2e)-2-[(1r,7r,10s,12r)-14-acetamido-7,14-dimethyl-4-oxo-6-azatetracyclo[8.3.1.02,6.07,12]tetradec-2-en-5-ylidene]acetate 5470606 NSC703547 resistant
hsa-miR-132-3p Methyl 2-(4,6-dimethyl-3-oxospiro[1h-indene-2,5'-3,4-dihydropyrazole]-4'-yl)benzoate 386181 NSC677803 sensitive
hsa-miR-132-3p Methyl 2-[[4,6-bis[hydroxy(methyl)amino]-1,3,5-triazin-2-yl]amino]acetate 45029484 NSC746930 resistant
hsa-miR-132-3p Methyl 2-[2-[3-hydroxy-3-(2-methoxy-2-oxo-ethyl)indol-2-yl]-1h-indol-3-yl]acetate 392215 NSC692348 resistant
hsa-miR-132-3p Methyl 4-[3-(2-thienyl)quinoxalin-2-yl]oxybenzoate 388002 NSC682365 sensitive
hsa-miR-132-3p Methyl 6-[[(3S,4aR,6aR,6bS,8R,8aR,12aS,14aR,14bR)-8a-[3-[4-[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-6-methyl-5-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxycarbonyl-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3, 385536 NSC676794 sensitive
hsa-miR-132-3p Methyl n-[6-(methoxycarbonylamino)pyren-1-yl]carbamate;methyl n-[8-(methoxycarbonylamino)pyren-1-yl]carbamate NSC33092 sensitive
hsa-miR-132-3p Michler's thione 71045 NSC30656 sensitive
hsa-miR-132-3p Miltefosin c 3599 NSC605583 resistant
hsa-miR-132-3p Mitomycin c,methylamine fr. streptomyces caespitosus 213803 NSC329086 sensitive
hsa-miR-132-3p N'-(4-chlorobenzoyl)-n-[(e)-1-(2-hydroxyphenyl)ethylideneamino]-n'-(4-methylphenyl)propanediamide 135499196 NSC644474 resistant
hsa-miR-132-3p N-(1,3-benzothiazol-2-yl)-2-phenyl-7-(3,4,5-trimethoxyphenyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide 71624130 NSC763635 sensitive
hsa-miR-132-3p N-(2,3-dimethyl-7-nitroquinolin-4-yl)-N',N'-dimethylpropane-1,3-diamine;hydrochloride 372712 NSC648273 sensitive
hsa-miR-132-3p N-(4-aziridinylbutyl)-1,3-diaminopropane 160395 NSC658397 resistant
hsa-miR-132-3p N-(6-methyl-1,3-benzothiazol-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1h-2-benzofuran-1-yl)butanamide 369455 NSC641225 sensitive
hsa-miR-132-3p N-[(e)-(2,4-dihydroxyphenyl)methylideneamino]-3-[[2-(trifluoromethyl)pyridin-4-yl]amino]benzamide 135968269 NSC748262 resistant
hsa-miR-132-3p N-[(E)-(2,4-dihydroxyphenyl)methylideneamino]-8-ethoxy-4-hydroxy-1-oxo-6-phenyl-2H-2,7-naphthyridine-3-carboxamide 135968282 NSC747284 resistant
hsa-miR-132-3p N-[(e)-(5-chloro-2-hydroxyphenyl)methylideneamino]-2-[[2-(trifluoromethyl)pyridin-4-yl]amino]benzamide 135968273 NSC747459 resistant
hsa-miR-132-3p N-[(e)-[4-(diethylamino)-2-hydroxyphenyl]methylideneamino]-2-[[2-(trifluoromethyl)pyridin-4-yl]amino]benzamide 135968272 NSC747458 resistant
hsa-miR-132-3p N-[(e)-[4-(diethylamino)-2-hydroxyphenyl]methylideneamino]-4-[[2-(trifluoromethyl)pyridin-4-yl]amino]benzamide 135968274 NSC747460 resistant
hsa-miR-132-3p N-[(E)-1-(6-methylpyridin-2-yl)ethylideneamino]-3-azabicyclo[3.2.2]nonane-3-carbothioamide 5464837 NSC335789 resistant
hsa-miR-132-3p N-[(Z)-[[4-[bis(2-cyanoethyl)amino]-2-methylphenyl]-[(4-methoxyphenyl)diazenyl]methylidene]amino]benzamide 135493921 NSC681972 sensitive
hsa-miR-132-3p N-[2-(hydrazinecarbonyl)-4-nitrophenyl]adamantane-1-carboxamide 5472393 NSC718359 resistant
hsa-miR-132-3p N-[3-[2-[(7-chloroquinolin-4-yl)amino]ethyl-ethylamino]propyl]-2-[7-(dimethylamino)-2-oxochromen-4-yl]acetamide 49856402 NSC754328 sensitive
hsa-miR-132-3p N-[4-[(2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl)oxy]butyl]-1h-indole-2-carboxamide 20826874 NSC726365 resistant
hsa-miR-132-3p N-[4-[hydroxy(methyl)amino]-6-(propylamino)-1,3,5-triazin-2-yl]-n-methylhydroxylamine 45029482 NSC746928 resistant
hsa-miR-132-3p Naphth[2,3-d]oxazol-9-one, 2-methyl-4-(phenylimino)- 160386 NSC650573 sensitive
hsa-miR-132-3p Naphthalene-1,2-dione, 1,2-dihydro-4-[(3-pyridinyl)amino]- 367787 NSC637729 sensitive
hsa-miR-132-3p Neuro_000310 368991 NSC640500 resistant
hsa-miR-132-3p Pan (van) 6825 NSC5332 resistant
hsa-miR-132-3p Questiomycin a 72725 NSC94945 sensitive
hsa-miR-132-3p Resorufin 69462 NSC12097 sensitive
hsa-miR-132-3p S-(3,5-dioxo-2h-1,2,4-triazin-6-yl) phenazine-1-carbothioate 403975 NSC719923 sensitive
hsa-miR-132-3p Toddalin 5351594 NSC76023 sensitive
hsa-miR-132-3p Tributylgermyl 3-oxo-3-phenyl-propanoate 16683249 NSC653557 sensitive
hsa-miR-132-3p Tributyrin 6050 NSC661583 resistant
hsa-miR-132-3p Tris(1,10-phenanthroline)lanthanum(iii)-trithiocyanate 24202211 NSC632737 resistant
hsa-miR-132-3p Tris(1,10-phenanthroline)neodymium(iii)-trithiocyanate 24202207 NSC632730 resistant
hsa-miR-132-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-132-3p Doxorubicin 31703 NSC123127 approved resistant High Ovarian Cancer cell line (OV19, TOV21G, TOV112D, FUOV1, C13, OV2008, A2780CP, A2780S, IGROV1, T8, OVCAR5, IMCC3, A2008, OVCAR3, SKOV3, IOSER)
hsa-miR-132-3p Verapamil 2520 NSC272366 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-132-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-132-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-132-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-132-3p 10-Hydroxycamptothecin 97226 NSC107124 resistant High Gastric Cancer cell line (BGC823, SGC-7901, MGC-803, HGC-27, NCI-N87, AGS)
hsa-miR-132-3p Paroxetine 43815 approved sensitive High Normal lymphoblastoid cell line
hsa-miR-132-3p Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (H358, H1993)
hsa-miR-132-3p Chemotherapy resistant High Osteosarcoma tissue
hsa-miR-132-3p Fluorouracil 3385 NSC19893 approved sensitive High Pancreatic Cancer cell line (PANC-1)
hsa-miR-132-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (PANC-1)
hsa-miR-132-3p Gefitinib 123631 NSC715055 approved resistant High Lung Adenocarcinoma cell line (A549)
hsa-miR-132-3p Plx-4720 24180719 NSC757438 resistant High Thyroid Cancer cell line (8505c, BCPAP)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-132-3p Platinum 23939 resistant High Ovarian Cancer tissue
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved sensitive Low Cervical Cancer tissue
hsa-miR-132-3p Tamoxifen 2733525 NSC180973 approved resistant High Breast Cancer cell line (TAMR1)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved resistant Low Gastric Cancer cell line (MKN45, MKN28)
hsa-miR-132-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-132-3p Temozolomide 5394 NSC362856 approved resistant Low Glioblastoma cell line (U87MG)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved sensitive Low Nasopharyngeal Cancer cell line (CNE2)
hsa-miR-132-3p Doxorubicin 31703 NSC123127 approved resistant Low Breast Cancer tissue and cell line (MCF-7)
hsa-miR-132-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-132-3p Panobinostat 6918837 NSC761190 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-132-3p Trametinib 11707110 NSC758246 approved resistant High Melanoma cell line (WM266) (2uM)
hsa-miR-132-3p Trametinib 11707110 NSC758246 approved resistant High Melanoma cell line (WM266) (200nM)
hsa-miR-132-3p Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (WM266) (1uM)
hsa-miR-132-3p Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (WM266) (500nM)
hsa-miR-132-3p Trametinib 11707110 NSC758246 approved resistant High Melanoma cell line (WM266) (500nM)
hsa-miR-132-3p Trametinib 11707110 NSC758246 approved resistant High Melanoma cell line (WM266) (1uM)
hsa-miR-132-3p Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (WM266) (2uM)
hsa-miR-132-3p Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (WM266) (200nM)
hsa-miR-132-3p Gefitinib 123631 NSC715055 approved resistant High Non-Small Cell Lung Cancer tissue
hsa-miR-132-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKVO3ip1, HeyA8)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved resistant High Ovarian Cancer cell line (A2780)
hsa-miR-132-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-132-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) resistant High Metastatic Colorectal Cancer tissue
hsa-miR-132-3p Trastuzumab resistant High Breast Cancer cell line (MDA‐MB‐231, SKBR3, HEK‐293T)
hsa-miR-132-3p Fluorouracil 3385 NSC19893 approved resistant High Gastric Cancer cell line (MGC-803)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved sensitive Low Oral Cancer cell line (CAL-27)
hsa-miR-132-3p Sorafenib 216239 NSC747971 approved sensitive Low Hepatocellular Carcinoma cell line (MHCC97)
hsa-miR-132-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3ip1, HeyA8)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved resistant High Ovarian Cancer cell line (A2780CP20)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved resistant High Ovarian Cancer cell line (A2780CIS)
hsa-miR-132-3p Etoposide 36462 NSC141540 approved sensitive Low Breast Cancer cell line
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved resistant High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-132-3p Antiepileptic Drug sensitive High Pediatric Epilepsy tissue
hsa-miR-132-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (451Lu)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved sensitive cell line
hsa-miR-132-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-132-3p Paclitaxel 36314 NSC125973 approved resistant cell line (HeyA8)
hsa-miR-132-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM17)
hsa-miR-132-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-132-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (BAS)
hsa-miR-132-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CP20)
hsa-miR-132-3p Ribavirin+Pegylated IFNa-2b resistant tissue (chronic hepatitis C)
hsa-miR-132-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A2780)
hsa-miR-132-3p Fluorouracil 3385 NSC19893 approved resistant cell line (HCT15)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A2780)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-132-3p Sunitinib 5329102 NSC750690 approved sensitive tissue (CardA)
hsa-miR-132-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-132-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR1)
hsa-miR-132-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM16)
hsa-miR-132-3p Ceritinib 57379345 NSC776422 approved sensitive cell line (H3122)
hsa-miR-132-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A2780)
hsa-miR-132-3p Cetuximab resistant tissue (colorectal carcinoma)
hsa-miR-132-3p Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide/Methotrexate/Gemcitabine sensitive cell line (Bats-72)
hsa-miR-132-3p Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide sensitive cell line (Bads-200)

Error report submission